Related references
Note: Only part of the references are listed.Cyclodextrin modified erlotinib loaded PLGA nanoparticles for improved therapeutic efficacy against non-small cell lung cancer
Bhuvaneshwar Vaidya et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)
Induction of AMPK activation by N,N′-diarylurea FND-4b decreases growth and increases apoptosis in triple negative and estrogen-receptor positive breast cancers
Jeremy Johnson et al.
PLOS ONE (2019)
Tyrosine kinase inhibitor conjugated quantum dots for non-small cell lung cancer (NSCLC) treatment
Nishant S. Kulkarni et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Metformin as Anti-Aging Therapy: Is It for Everyone?
Alexander A. Soukas et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2019)
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Metformin and cancer: An existing drug for cancer prevention and therapy (Review)
Fuming Zi et al.
ONCOLOGY LETTERS (2018)
Metformin synergistically suppress tumor growth with doxorubicin and reverse drug resistance by inhibiting the expression and function of P-glycoprotein in MCF7/ADR cells and xenograft models
Ying Li et al.
ONCOTARGET (2018)
Nano-encapsulated metformin-curcumin in PLGA/PEG inhibits synergistically growth and hTERT gene expression in human breast cancer cells
Raana Farajzadeh et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2018)
Metformin reduces the risk of cancer in patients with type 2 diabetes An analysis based on the Korean National Diabetes Program Cohort
Hae Jin Kim et al.
MEDICINE (2018)
Metformin as an anti-cancer agent: actions and mechanisms targeting cancer stem cells
Nipun Saini et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2018)
Incidence and Mortality and Epidemiology of Breast Cancer in the World
Mahshid Ghoncheh et al.
Asian Pacific Journal of Cancer Prevention (2017)
Metformin Inhibits Tumorigenesis and Tumor Growth of Breast Cancer Cells by Upregulating miR-200c but Downregulating AKT2 Expression
Jiali Zhang et al.
JOURNAL OF CANCER (2017)
Liposomal Formulations in Clinical Use: An Updated Review
Upendra Bulbake et al.
PHARMACEUTICS (2017)
Metformin: historical overview
Clifford J. Bailey
DIABETOLOGIA (2017)
Cancer cell motility: lessons from migration in confined spaces
Colin D. Paul et al.
NATURE REVIEWS CANCER (2017)
Mechanism of metformin action in MCF-7 and MDA-MB-231 human breast cancer cells involves oxidative stress generation, DNA damage, and transforming growth factor β1 induction
Poliana Camila Marinello et al.
TUMOR BIOLOGY (2016)
Metformin induces apoptosis via a mitochondria-mediated pathway in human breast cancer cells in vitro
Zhen-Yuan Gao et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2016)
Metformin, an Old Drug, Brings a New Era to Cancer Therapy
Huan He et al.
CANCER JOURNAL (2015)
Liposomes as nanomedical devices
Giuseppina Bozzuto et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2015)
Comparison of 2D-and 3D-culture models as drug-testing platforms in breast cancer
Yoshinori Imamura et al.
ONCOLOGY REPORTS (2015)
The anti-proliferative effect of metformin in triple-negative MDA-MB-231 breast cancer cells is highly dependent on glucose concentration: Implications for cancer therapy and prevention
Beshay N. M. Zordoky et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2014)
AMP-activated protein kinase (AMPK) beyond metabolism A novel genomic stress sensor participating in the DNA damage response pathway
Toran Sanli et al.
CANCER BIOLOGY & THERAPY (2014)
Liposomes as carriers of hydrophilic small molecule drugs: Strategies to enhance encapsulation and delivery
Josimar Oliveira Eloy et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2014)
Metformin reverses multidrug resistance and epithelial-mesenchymal transition (EMT) via activating AMP-activated protein kinase (AMPK) in human breast cancer cells
Chen Qu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2014)
Metformin reverses multidrug resistance in human hepatocellular carcinoma Bel-7402/5-fluorouracil cells
Sunbin Ling et al.
MOLECULAR MEDICINE REPORTS (2014)
Metformin Induces Apoptosis and Cell Cycle Arrest Mediated by Oxidative Stress, AMPK and FOXO3a in MCF-7 Breast Cancer Cells
Eveline A. I. F. Queiroz et al.
PLOS ONE (2014)
Formulation and evaluation of metformin hydrochloride-loaded niosomes as controlled release drug delivery system
Azza A. Hasan et al.
DRUG DELIVERY (2013)
Liposomal fasudil, a rho-kinase inhibitor, for prolonged pulmonary preferential vasodilation in pulmonary arterial hypertension
Vivek Gupta et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Breast cancer as a systemic disease: a view of metastasis
A. J. Redig et al.
JOURNAL OF INTERNAL MEDICINE (2013)
Current trends in the use of liposomes for tumor targeting
Pranali P. Deshpande et al.
NANOMEDICINE (2013)
Spheroid culture as a tool for creating 3D complex tissues
Eelco Fennema et al.
TRENDS IN BIOTECHNOLOGY (2013)
Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers
Xin-Sheng Deng et al.
CELL CYCLE (2012)
Antiproliferative action of metformin in human lung cancer cell lines
Hironori Ashinuma et al.
ONCOLOGY REPORTS (2012)
Comparative Effectiveness and Safety of Medications for Type 2 Diabetes: An Update Including New Drugs and 2-Drug Combinations
Wendy L. Bennett et al.
ANNALS OF INTERNAL MEDICINE (2011)
Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents
Pamela J. Goodwin et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
A high response rate to liposomal doxorubicin is seen among women with BRCA mutations treated for recurrent epithelial ovarian cancer
Sarah F. Adams et al.
GYNECOLOGIC ONCOLOGY (2011)
Metformin: Multi-faceted protection against cancer
Sonia Del Barco et al.
ONCOTARGET (2011)
3D Models of Epithelial-Mesenchymal Transition in Breast Cancer Metastasis: High-Throughput Screening Assay Development, Validation, and Pilot Screen
Qun Li et al.
JOURNAL OF BIOMOLECULAR SCREENING (2011)
Arthemeter-loaded lipid nanoparticles produced by modified thin-film hydration: Pharmacokinetics, toxicological and in vivo anti-malarial activity
N. P. Aditya et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
AMPK as a metabolic tumor suppressor: control of metabolism and cell growth
Zhijun Luo et al.
FUTURE ONCOLOGY (2010)
Metformin in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug?
Issam Ben Sahra et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Substance P promotes expansion of human mesenteric preadipocytes through proliferative and antiapoptotic pathways
Kara Gross et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2009)
Metformin induces unique biological and molecular responses in triple negative breast cancer cells
Bolin Liu et al.
CELL CYCLE (2009)
Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
Sao Jiralerspong et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Insulin-Lowering Effects of Metformin in Women with Early Breast Cancer
Pamela J. Goodwin et al.
CLINICAL BREAST CANCER (2008)
In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro
Chun-Chi Liang et al.
NATURE PROTOCOLS (2007)
Changes in cytosolic Ca2+ levels regulate Bcl-xS and Bcl-xL expression in spermatogenic cells during apoptotic death
DP Mishra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Metformin and reduced risk of cancer in diabetic patients
JMM Evans et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Recent advances with liposomes as pharmaceutical carriers
VP Torchilin
NATURE REVIEWS DRUG DISCOVERY (2005)
Share Paper
